C07D 233/66
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D233/66 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 3,351 US grants and 2,295 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,351
- Published applications
- 2,295
- Assignees
- 1,236
- Inventors
- 8,339
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 67 | 0 |
| 1977 | 67 | 0 |
| 1978 | 70 | 0 |
| 1979 | 60 | 0 |
| 1980 | 103 | 0 |
| 1981 | 72 | 0 |
| 1982 | 45 | 0 |
| 1983 | 43 | 0 |
| 1984 | 62 | 0 |
| 1985 | 47 | 0 |
| 1986 | 55 | 0 |
| 1987 | 55 | 0 |
| 1988 | 41 | 0 |
| 1989 | 56 | 0 |
| 1990 | 56 | 0 |
| 1991 | 63 | 0 |
| 1992 | 56 | 0 |
| 1993 | 70 | 0 |
| 1994 | 66 | 0 |
| 1995 | 62 | 0 |
| 1996 | 77 | 0 |
| 1997 | 91 | 0 |
| 1998 | 67 | 0 |
| 1999 | 77 | 0 |
| 2000 | 71 | 0 |
| 2001 | 79 | 7 |
| 2002 | 82 | 73 |
| 2003 | 71 | 118 |
| 2004 | 57 | 129 |
| 2005 | 71 | 108 |
| 2006 | 61 | 103 |
| 2007 | 68 | 108 |
| 2008 | 53 | 104 |
| 2009 | 55 | 102 |
| 2010 | 87 | 122 |
| 2011 | 74 | 99 |
| 2012 | 74 | 105 |
| 2013 | 84 | 90 |
| 2014 | 114 | 99 |
| 2015 | 78 | 99 |
| 2016 | 73 | 86 |
| 2017 | 91 | 96 |
| 2018 | 69 | 84 |
| 2019 | 58 | 77 |
| 2020 | 61 | 95 |
| 2021 | 67 | 76 |
| 2022 | 51 | 69 |
| 2023 | 53 | 88 |
| 2024 | 53 | 70 |
| 2025 | 38 | 44 |
| 2026 | 30 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Imidazole compounds as inhibitors of ENPP122 Sep 2026US 12,741,963 B2Stingray Therapeutics, Inc.
- Preparation process of 1-n-methyl-2-nitro-5-hydroxymethyl imidazole1 Sep 2026US 12,723,031 B2Ascentawits Pharmaceuticals, Ltd.
- Continuous method for preparing tricyanoimidazole28 Jul 2026US 12,692,237 B2Uchicago Argonne, LLC
- Substituted fluorine-containing imidazole salt compound, preparation method therefor, pharmaceutical composition thereof and use thereof7 Jul 2026US 12,673,921 B2Xiamen Vivohealths Technology Co., Ltd.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- 5-membered heteroaryl carboxamide compounds for treatment of hbv17 Sep 2026US 2026/0274823 A1Assembly Biosciences, Inc.
- Diamidine analogs for anti-inflammatory use10 Sep 2026US 2026/0263426 A1Montdorex Inc.
- Matrix metalloproteinase (mmp) inhibitors and methods of use thereof10 Sep 2026US 2026/0265232 A1Foresee Pharmaceuticals USA, Inc.
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
Most cited
By later US patents
- 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation222US 5,616,601 AG. D. Searle & Co. · 1997
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Amide derivatives176US 4,636,505 AImperial Chemical Industries PLC · 1987
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003